Dynamiker Biotechnology

Company Medical Device

Dynamiker Bio’s Aspergillus Detection Kit Wins NMPA Marketing Approval

Fineline Cube Jun 25, 2025

China-based Dynamiker Biotechnology (Tianjin) Co., Ltd. announced that it has received marketing approval from the...

Company

Dynamiker Biotechnology Receives Approval for IPO on Beijing Stock Exchange

Fineline Cube Dec 28, 2024

On December 27, 2024, the official website of the Beijing Stock Exchange announced that Dynamiker...

Company Drug

Hengrui Pharmaceuticals Wins NMPA Clinical Trial Approval for SHR‑1179 – First‑in‑Class Biological Candidate for Weight Management

Company Drug

Hualan Bio Wins NMPA Clinical Trial Approval for Novel Influenza mRNA Vaccine – China’s Vaccine Major Pushes into mRNA Platform

Others

METiS Therapeutics Partners with Hengrui Pharma – Deploying AiTEM AI Formulation Platform at China’s Leading Drugmaker

Company Deals PIC

Suzhou AsiFlyer Biotechnology Secures Exclusive Worldwide License from ShanghaiTech University for AI‑Designed Recombinant Botulinum Toxin Patent